What if you could read the DNA of your future child? | Noor Siddiqui
Summary
Noor Siddiqui, founder of Orchid, argues that whole-genome embryo sequencing is ending the "genetic lottery" by allowing parents to screen for thousands of diseases and complex health risks before birth. Motivated by her mother’s blindness, she explains how this technology reads the entire genome to prevent genetic disorders, contrasting it with limited standard IVF tests. The episode explores the ethical implications of selecting for health versus enhancing traits, while sharing stories of families who used the technology to avoid passing on severe conditions to subsequent children.
Topics discussed
Introduction: The end of the genetic lottery
Sponsor: Capital One AI car shopping
Sponsor: Apple Card end-of-year cash back
Sponsor: MSK Cancer Center breast cancer research
The probability of your existence
Personal story: Noor's mother's blindness
Orchid's whole genome sequencing technology
Technical challenges of embryo DNA amplification
Screening for diseases and risk reduction
The future of elective embryo screening
Case study: Mia's family and outcome
The power of single base pair mutations
Ethical perspective and final family story
Conclusion: Choosing health for the next generation
Q&A: Cost, access, and ethical boundaries
Closing credits and production team
Sponsor: Scribd knowledge platform
Sponsor: Land Rover Defender adventure
Sponsor: Capital One AI car shopping
Listen ad-free on Castria